With a career entirely within pharmaceuticals, I have obtained extensive experience and knowledge of pharmaceutical pricing in general, and of launch sequencing/launch sequence optimization and international reference pricing in particular. 

As the CEO of Two Scenarios, I specialize in optimizing prices for pharmaceutical companies in the light of international reference pricing. We strive to help our clients optimize their pricing process and save valuable money by assisting them with our deep technical knowledge of how international reference pricing really works. At Two Scenarios, agility is a key word: we are able to quickly develop and implement solutions for our clients to ensure that no time is wasted.